Home >> ALL ISSUES >> 2018 Issues >> Letters, 4/18

Letters, 4/18

image_pdfCreate PDF
  1. Masood S, Rosa M, Kraemer DF, Smotherman C, Mohammadi A. Comparative cost-effectiveness of fine needle aspiration biopsy versus image-guided biopsy, and open surgical biopsy in the evaluation of breast cancer in the era of Affordable Care Act: a changing landscape. Diagn Cytopathol. 2015;43(8):605–612.
  2. Masood S. Core needle biopsy versus fine needle aspiration biopsy: are there similar sampling and diagnostic issues? Clin Lab Med. 2005;25(4):679–688.
  3. The Association of Breast Surgery @ BASO, Royal College of Surgeons of England. Guidelines for the management of symptomatic breast disease. Eur J Surg Oncol. 2005;31:S1–21.
  4. Toomey DP, Cahill RA, Birido N, et al. Rapid assessment breast clinics—evolution through audit. Eur J Cancer. 2006;42(17):2961–2967.
  5. Bean GR, Scott V, Yee L, et al. Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev. 2005;14(4):790–798.

Shahla Masood, MD, Professor and Chair, Department of Pathology and Laboratory Medicine, University of Florida College of Medicine, Jacksonville
Chief of Pathology and Laboratory Medicine, Medical Director, UF Health, Jacksonville Breast Center

[hr]

 

CAP TODAY
X